DailyDoctor Archive Specialties Get app
All infectious diseases briefings

The edition · Infectious Diseases

Oropouche in pregnancy carries a threefold risk of fetal loss, and community AWaRe training cuts Watch antibiotic use

A Brazilian cohort quantifies harm from Oropouche virus in pregnancy; a cluster trial in two African districts shows prescriber and community education can shift broad-spectrum antibiotic use; and a shorter benznidazole course for Chagas disease is better tolerated.

The edition in brief

In a prospective cohort of 544 pregnant women in Rio de Janeiro state, confirmed Oropouche virus infection was associated with adverse maternal outcomes in 18% versus 7% (aRR 2.90), with roughly threefold risks of fetal loss and haemorrhage and CNS abnormalities in 8% of infants against none in uninfected pregnancies; 38% of confirmed infections had no symptoms. The CABU-EICO cluster-randomised trial in 44 villages in Burkina Faso and DR Congo found that a nine-month bundle of community education and provider training in WHO AWaRe guidance reduced Watch-group antibiotic use (adjusted prevalence ratio 0.33) without worsening simulated-patient management. The TESEO phase 2b trial in 450 Bolivian adults with chronic Chagas disease found benznidazole 150 mg once daily for 30 days non-inferior to the standard 60-day twice-daily course, with drug-related adverse events in 37% versus 60%. A laboratory study of 191 people found that smallpox vaccination and prior clade IIb mpox infection produced little neutralising antibody against clade Ib. The pearl covers the AWaRe groups for everyday prescribing.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free